At the news
? NEUTRALIMPACT 1/10 144 filed Oct 30, 2026 at 16:20 ET
Director George J. Morrow filed a Form 144 notice of intent to sell 300 shares of Neurocrine Biosciences common stock, valued at approximately $43,914 based on the filing date. The shares were acquired through option exercise on the same date. The proposed sale is very small relative to the company's $14.8B market cap and represents a routine insider transaction.
- Director George J. Morrow filed Form 144 to sell 300 shares of NBIX common stock.
- Estimated value of proposed sale: $43,914 (based on filing date).
- Shares were acquired via option exercise on 10/30/2026.
- Sale is immaterial relative to NBIX's $14.8B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access